Human Genetics, Год журнала: 2025, Номер unknown
Опубликована: Апрель 21, 2025
Язык: Английский
Human Genetics, Год журнала: 2025, Номер unknown
Опубликована: Апрель 21, 2025
Язык: Английский
Current Issues in Molecular Biology, Год журнала: 2025, Номер 47(2), С. 90 - 90
Опубликована: Янв. 31, 2025
Chimeric antigen receptor-T (CAR-T) cell therapy has demonstrated impressive efficacy in the treatment of blood cancers; however, its effectiveness against solid tumors been significantly limited. The differences arise from a range difficulties linked to tumors, including an unfriendly tumor microenvironment, variability within and barriers CAR-T infiltration longevity at location. Research shows that reasons for decreased cells treating are not well understood, highlighting ongoing need strategies address these challenges. Current frequently incorporate combinatorial therapies designed boost functionality enhance their capacity effectively target tumors. However, remain testing phase necessitate additional validation assess potential benefits. CAR-NK (natural killer), CAR-iNKT (invariant natural killer T), CAR-M (macrophage) emerging as promising Recent studies highlight construction optimization cells, emphasizing overcome unique challenges posed by such hypoxia metabolic barriers. This review focuses on CAR
Язык: Английский
Процитировано
0International Journal of Biological Macromolecules, Год журнала: 2025, Номер unknown, С. 142401 - 142401
Опубликована: Март 1, 2025
Язык: Английский
Процитировано
0Progress in Biophysics and Molecular Biology, Год журнала: 2025, Номер unknown
Опубликована: Апрель 1, 2025
Язык: Английский
Процитировано
0Human Genetics, Год журнала: 2025, Номер unknown
Опубликована: Апрель 21, 2025
Язык: Английский
Процитировано
0